Back to top
more

Cigna Group (CI)

(Delayed Data from NYSE)

$344.50 USD

344.50
2,809,280

-12.68 (-3.55%)

Updated May 2, 2024 04:00 PM ET

After-Market: $344.40 -0.10 (-0.03%) 7:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 21% (199 out of 251)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Zacks Industry Outlook Highlights Cigna, Centene and Molina Healthcare

by Zacks Equity Research

Cigna, Centene and Molina Healthcare have been highlighted in this Industry Outlook article.

Debasmita Chatterjee headshot

3 HMO Stocks in Focus Despite High Tech Costs & Nursing Shortage

by Debasmita Chatterjee

Growing customer base and M&A strategies are likely to aid the Medical-HMO industry. However, escalating expenses and a dearth in the availability of medical personnel are concerning. Stocks like CI, CNC and MOH are likely to navigate the industry storms.

Derek Lewis headshot

Dividend Watch: 3 Companies Boosting Payouts

by Derek Lewis

Companies that boost their dividend payouts reflect a successful and shareholder-friendly nature, opting to share a portion of profits with investors. Who doesn't like payday?

Molina Healthcare (MOH) Q4 Earnings Beat on Premium Growth

by Zacks Equity Research

Molina Healthcare (MOH) expects adjusted EPS to be at a minimum of $23.5 in 2024, which represents a year-over-year improvement of 12.5%.

Cigna Group (CI) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

Cigna (CI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Cencora (COR) and Cigna (CI) have performed compared to their sector so far this year.

Ritujay Ghosh headshot

5 Stocks to Watch That Recently Announced Dividend Hikes

by Ritujay Ghosh

PACCAR Inc (PCAR), Church & Dwight Co., Inc. (CHD), Imperial Oil Limited (IMO), Ramaco Resources, Inc. (METC) and The Cigna Group (CI) recently hiked their dividends.

Centene (CNC) Q4 Earnings Beat on Membership Growth, View Up

by Zacks Equity Research

Centene (CNC) expects adjusted EPS to be a minimum of $6.70 in 2024, higher than the 2023 figure of $6.68 per share.

Cigna (CI) is a Top-Ranked Value Stock: Should You Buy?

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Analyst Blog Highlights Meta Platforms, Eaton, The Cigna, Colgate-Palmolive and Parker-Hannifin

by Zacks Equity Research

Meta Platforms, Eaton, The Cigna, Colgate-Palmolive and Parker-Hannifin are included in this Analyst Blog.

Sheraz Mian headshot

Top Analyst Reports for Meta Platforms, Eaton & Cigna

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Eaton Corporation plc (ETN) and The Cigna Group (CI).

Ensign Group (ENSG) Q4 Earnings Beat, Stock Up 5%

by Zacks Equity Research

Ensign Group's (ENSG) fourth-quarter results were aided by improved same-store occupancy and an increase in rental revenues. Management expects 2024 adjusted EPS within $5.29-$5.47.

Cigna (CI) Q4 Earnings Beat on Membership Growth, Dividend Up

by Zacks Equity Research

Cigna (CI) expects adjusted revenues to register a minimum growth of 20.3% from the 2023 reported figure.

Compared to Estimates, Cigna (CI) Q4 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Cigna (CI) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Cigna (CI) delivered earnings and revenue surprises of 4.14% and 4.77%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Cigna (CI) to Report Q4 Earnings: Can Rising Expenses Hurt?

by Zacks Equity Research

Cigna's (CI) fourth-quarter results are likely to reflect growth in Evernorth revenues and customer base.

Earnings Preview: Centene (CNC) Q4 Earnings Expected to Decline

by Zacks Equity Research

Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Curious about Cigna (CI) Q4 Performance? Explore Wall Street Estimates for Key Metrics

by Zacks Equity Research

Beyond analysts' top -and-bottom-line estimates for Cigna (CI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

Cigna (CI) Increases Yet Falls Behind Market: What Investors Need to Know

by Zacks Equity Research

Cigna (CI) closed at $298.88 in the latest trading session, marking a +0.36% move from the prior day.

Cigna (CI) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cigna (CI) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Cigna (CI) reachead $305.03 at the closing of the latest trading day, reflecting a +0.98% change compared to its last close.

Mark Vickery headshot

Top Stock Reports for NVIDIA, Boeing & Sony

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), The Boeing Company (BA) and Sony Group Corporation (SONY).

Can UnitedHealth's (UNH) UnitedHealthcare Unit Aid Q4 Earnings?

by Zacks Equity Research

UnitedHealth's (UNH) fourth-quarter results are expected to benefit from an increase in UnitedHealthcare's Medicare & Retirement revenues as well as the number of people it served.

Are Medical Stocks Lagging Cigna Group (CI) This Year?

by Zacks Equity Research

Here is how Cigna (CI) and Akoya Biosciences (AKYA) have performed compared to their sector so far this year.

Can UnitedHealth (UNH) Q4 Earnings Navigate Through High Costs?

by Zacks Equity Research

UnitedHealth's (UNH) fourth-quarter results are likely to reflect growth in domestic commercial customers and premium levels.